Pharmarise Holdings Corporation (2796.T)
JPY 563.0
(-2.26%)
JPY 563.0
(-2.26%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 54.46 Billion JPY | 4.68% |
| 2022 | 52.03 Billion JPY | 0.82% |
| 2021 | 51.6 Billion JPY | -1.37% |
| 2020 | 52.32 Billion JPY | 2.54% |
| 2019 | 51.03 Billion JPY | -1.35% |
| 2018 | 51.72 Billion JPY | -5.19% |
| 2017 | 54.56 Billion JPY | 3.05% |
| 2016 | 52.94 Billion JPY | 9.15% |
| 2015 | 48.51 Billion JPY | 22.8% |
| 2014 | 39.5 Billion JPY | 3.36% |
| 2013 | 38.22 Billion JPY | 14.58% |
| 2012 | 33.35 Billion JPY | 12.67% |
| 2011 | 29.6 Billion JPY | 10.37% |
| 2010 | 26.82 Billion JPY | 14.55% |
| 2009 | 23.41 Billion JPY | 17.04% |
| 2008 | 20 Billion JPY | 7.7% |
| 2007 | 18.57 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 15.23 Billion JPY | 10.43% |
| 2023 Q2 | 13.47 Billion JPY | 0.04% |
| 2023 Q1 | 13.47 Billion JPY | 1.29% |
| 2023 Q4 | 13.79 Billion JPY | 0.48% |
| 2023 Q3 | 13.72 Billion JPY | 1.85% |
| 2023 FY | 54.46 Billion JPY | 4.68% |
| 2022 Q3 | 12.98 Billion JPY | 0.78% |
| 2022 FY | 52.03 Billion JPY | 0.82% |
| 2022 Q1 | 12.86 Billion JPY | -1.29% |
| 2022 Q2 | 12.88 Billion JPY | 0.18% |
| 2022 Q4 | 13.3 Billion JPY | 2.43% |
| 2021 Q4 | 13.02 Billion JPY | 2.78% |
| 2021 Q3 | 12.67 Billion JPY | -1.28% |
| 2021 Q2 | 12.84 Billion JPY | -1.69% |
| 2021 Q1 | 13.06 Billion JPY | -5.79% |
| 2021 FY | 51.6 Billion JPY | -1.37% |
| 2020 Q2 | 12.78 Billion JPY | -0.75% |
| 2020 FY | 52.32 Billion JPY | 2.54% |
| 2020 Q4 | 13.86 Billion JPY | 8.38% |
| 2020 Q1 | 12.88 Billion JPY | 3.57% |
| 2020 Q3 | 12.79 Billion JPY | 0.06% |
| 2019 Q2 | 12.84 Billion JPY | -0.5% |
| 2019 Q1 | 12.91 Billion JPY | -2.31% |
| 2019 FY | 51.03 Billion JPY | -1.35% |
| 2019 Q4 | 12.43 Billion JPY | -3.08% |
| 2019 Q3 | 12.83 Billion JPY | -0.12% |
| 2018 Q4 | 13.21 Billion JPY | 2.86% |
| 2018 FY | 51.72 Billion JPY | -5.19% |
| 2018 Q3 | 12.85 Billion JPY | 0.64% |
| 2018 Q2 | 12.76 Billion JPY | -0.94% |
| 2018 Q1 | 12.89 Billion JPY | -5.41% |
| 2017 FY | 54.56 Billion JPY | 3.05% |
| 2017 Q3 | 13.7 Billion JPY | 0.49% |
| 2017 Q1 | 13.59 Billion JPY | -9.34% |
| 2017 Q2 | 13.63 Billion JPY | 0.29% |
| 2017 Q4 | 13.62 Billion JPY | -0.55% |
| 2016 Q3 | 12.71 Billion JPY | 1.22% |
| 2016 Q1 | 12.67 Billion JPY | -5.75% |
| 2016 Q2 | 12.56 Billion JPY | -0.87% |
| 2016 Q4 | 14.99 Billion JPY | 17.94% |
| 2016 FY | 52.94 Billion JPY | 9.15% |
| 2015 Q2 | 10.97 Billion JPY | 5.7% |
| 2015 FY | 48.51 Billion JPY | 22.8% |
| 2015 Q1 | 10.38 Billion JPY | 1.03% |
| 2015 Q4 | 13.44 Billion JPY | -1.87% |
| 2015 Q3 | 13.7 Billion JPY | 24.82% |
| 2014 Q3 | 9.91 Billion JPY | 0.54% |
| 2014 Q4 | 10.28 Billion JPY | 3.65% |
| 2014 Q2 | 9.86 Billion JPY | 4.49% |
| 2014 Q1 | 9.44 Billion JPY | -9.24% |
| 2014 FY | 39.5 Billion JPY | 3.36% |
| 2013 Q2 | 9.25 Billion JPY | 1.19% |
| 2013 Q3 | 9.42 Billion JPY | 1.87% |
| 2013 FY | 38.22 Billion JPY | 14.58% |
| 2013 Q4 | 10.4 Billion JPY | 10.38% |
| 2013 Q1 | 9.14 Billion JPY | -7.54% |
| 2012 Q3 | 8.47 Billion JPY | 12.42% |
| 2012 Q2 | 7.53 Billion JPY | 1.06% |
| 2012 Q1 | 7.45 Billion JPY | -2.87% |
| 2012 FY | 33.35 Billion JPY | 12.67% |
| 2012 Q4 | 9.88 Billion JPY | 16.7% |
| 2011 Q4 | 7.67 Billion JPY | -0.13% |
| 2011 FY | 29.6 Billion JPY | 10.37% |
| 2011 Q2 | 7.16 Billion JPY | 1.25% |
| 2011 Q3 | 7.68 Billion JPY | 7.32% |
| 2011 Q1 | 7.07 Billion JPY | -1.19% |
| 2010 Q3 | 6.71 Billion JPY | 2.16% |
| 2010 Q4 | 7.16 Billion JPY | 6.6% |
| 2010 FY | 26.82 Billion JPY | 14.55% |
| 2010 Q1 | 6.37 Billion JPY | -2.25% |
| 2010 Q2 | 6.57 Billion JPY | 3.21% |
| 2009 Q2 | 5.37 Billion JPY | 2.44% |
| 2009 Q3 | 6.27 Billion JPY | 16.7% |
| 2009 FY | 23.41 Billion JPY | 17.04% |
| 2009 Q1 | 5.24 Billion JPY | -0.31% |
| 2009 Q4 | 6.51 Billion JPY | 3.87% |
| 2008 Q3 | 5.05 Billion JPY | 2.53% |
| 2008 FY | 20 Billion JPY | 7.7% |
| 2008 Q2 | 4.93 Billion JPY | 0.0% |
| 2008 Q4 | 5.26 Billion JPY | 4.07% |
| 2007 FY | 18.57 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| HEARTSEED INC | 344.72 Million JPY | -15699.84% |
| Cawachi Limited | 285.96 Billion JPY | 80.953% |
| Qol Holdings Co., Ltd. | 180.05 Billion JPY | 69.75% |
| MatsukiyoCocokara & Co. | 1022.53 Billion JPY | 94.673% |
| Welcia Holdings Co., Ltd. | 1217.33 Billion JPY | 95.526% |
| Create SD Holdings Co., Ltd. | 422.33 Billion JPY | 87.103% |
| NIHON CHOUZAI Co.,Ltd. | 340.31 Billion JPY | 83.995% |
| COSMOS Pharmaceutical Corporation | 964.98 Billion JPY | 94.356% |
| Tsuruha Holdings Inc. | 1027.46 Billion JPY | 94.699% |
| Ohki Healthcare Holdings Co.,Ltd. | 334.66 Billion JPY | 83.725% |
| Satudora Holdings Co.,Ltd. | 95.52 Billion JPY | 42.979% |
| Kusuri No Aoki Holdings Co., Ltd. | 436.87 Billion JPY | 87.533% |
| Medical System Network Co., Ltd. | 115.36 Billion JPY | 52.786% |
| Shinnihonseiyaku Co., Ltd. | 37.65 Billion JPY | -44.652% |
| Sugi Holdings Co.,Ltd. | 744.47 Billion JPY | 92.684% |
| YAKUODO HOLDINGS Co., Ltd. | 142.24 Billion JPY | 61.709% |
| Astena Holdings Co., Ltd. | 51.98 Billion JPY | -4.774% |
| Genky DrugStores Co., Ltd. | 184.86 Billion JPY | 70.537% |
| Ain Holdings Inc. | 399.82 Billion JPY | 86.378% |
| Sundrug Co.,Ltd. | 751.77 Billion JPY | 92.755% |